Home
This site is intended for healthcare professionals
Sign upLog in
MedAll Oncology
MedAll Oncology
Soumya Ranjan Mallick
Vijendra Mosalpuria
Mahmoud Elrefaei
Ahmed Mohamed
Safwan A Mohamed
Mazin Albahi
Hibah Bileid Bakeer
Harshal Ramkrishna
Gemma Thomas
Alireza Pourrahim
Wara Qazi
Mennatuallah Ashour
Team MedAll
Muhammad Hassan
Kavinda Perera
Mariam Alwadda
karrar Al-balootti
Soumya Ranjan Mallick
Vijendra Mosalpuria
Mahmoud Elrefaei
Ahmed Mohamed
Safwan A Mohamed
Mazin Albahi
Hibah Bileid Bakeer
Harshal Ramkrishna
Gemma Thomas
Alireza Pourrahim
Wara Qazi
Mennatuallah Ashour
15 members, 1218 followers
OverviewEvents & videosThreadsResourcesPeopleAbout
Patient Leaflets for Clinical Oncology
1L HER2+ / HR+ MBC: Integration Map
Advanced Prostate Cancer Question Bank
Appraising and Applying Clinical Trial Data in Advanced Prostate Cancer: Key Clinical Summary
Bladder Cancer Advocacy Network (BCAN) - Patient Educational Materials Flyer
Differentiation of emerging endocrine therapies in ER⁺/HER2⁻ mBC based on MoA and clinical role
Emerging Therapies and Multidisciplinary Management in Advanced Prostate Cancer: Key Clinical Summary
HER2+ MBC Updates from San Antonio Breast Cancer Symposium 2025
Key Clinical Summary: BRAF-driven treatment decisions - Biomarker testing in practice
Key Clinical Summary: BRAF-driven treatment decisions - First line personalization and adverse events management
Key Clinical Summary: BRAF-driven treatment decisions - The patient perspective
Key Clinical Summary: Cancer Cachexia Update: Focus on Emerging Therapies
Key Clinical Summary: Cancer Cachexia – The Patient Perspective
Key Clinical Summary: Cancer Cachexia: Early Recognition and Comprehensive Care
Key Clinical Summary: Cancer Cachexia: Multimodal Interventions and Multidisciplinary Management
Key Clinical Summary: Evolution and Rationale for Maintenance De-Escalation in 1L HER2⁺ MBC
Key Clinical Summary: Optimizing Maintenance in HER2+ Metastatic Breast Cancer
Key Clinical Summary: The Role of Endocrine Therapy ± CDK4/6 Inhibitors in HER2+/HR+ MBC 1L Setting
MedAll Education Link
Navigating Treatment Decisions in Metastatic Prostate Cancer: Key Clinical Summary
Optimize post-CDK4/6 sequencing in ER⁺/HER2⁻ mBC based on clinical and molecular resistance patterns
Optimizing Maintenance in HER2+ Metastatic Breast Cancer: A thread
Personalizing Therapy in ER⁺/HER2⁻ Metastatic Breast Cancer via Biomarkers and Evidence-Based Decision-Making
Relapsed/Refractory Multiple Myeloma Question Bank